Cargando…
AHCC(®) Supplementation to Support Immune Function to Clear Persistent Human Papillomavirus Infections
OBJECTIVE: To determine the efficacy, safety, and durability of the use of AHCC supplementation for 6 months to support the host immune system to clear high-risk human papillomavirus (HPV) infections. The AHCC supplement is a proprietary, standardized extract of cultured lentinula edodes mycelia (AH...
Autores principales: | Smith, Judith A., Gaikwad, Anjali A., Mathew, Lata, Rech, Barbara, Faro, Jonathan P., Lucci, Joseph A., Bai, Yu, Olsen, Randall J., Byrd, Teresa T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9256908/ https://www.ncbi.nlm.nih.gov/pubmed/35814366 http://dx.doi.org/10.3389/fonc.2022.881902 |
Ejemplares similares
-
From Bench to Bedside: Evaluation of AHCC Supplementation to Modulate the Host Immunity to Clear High-Risk Human Papillomavirus Infections
por: Smith, Judith A., et al.
Publicado: (2019) -
Evaluation of Active Hexose Correlated Compound (AHCC) in Combination With Anticancer Hormones in Orthotopic Breast Cancer Models
por: Mathew, Lata, et al.
Publicado: (2017) -
Effects of AHCC® on Immune and Stress Responses in Healthy Individuals
por: Takanari, Jun, et al.
Publicado: (2018) -
Nucleotides and AHCC Enhance Th1 Responses In Vitro in Leishmania-Stimulated/Infected Murine Cells
por: Dea-Ayuela, María Auxiliadora, et al.
Publicado: (2020) -
Oral Supplementation with AHCC(®), a Standardized Extract of Cultured Lentinula edodes Mycelia, Enhances Host Resistance against SARS-CoV-2 Infection
por: Singh, Ankita, et al.
Publicado: (2023)